Deciphera Pharmaceuticals DCPH 深 滬
已收盤 06-11 16:00:00 美东时间
25.59
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 25.59
- 總市值 20.68亿
- 52周最高 25.61
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 9.90
- 委 比 0.00%
- 總股本 8080.01万
- 歷史最高 71.11
- 量 比 0
- 振 幅 0.00%
- 歷史最低 6.51
- 每 手 1
- 風險率 4.57%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多J.P. Morgan Life Sciences Private Capital Welcomes Dashyant Dhanak, Ph.D. as Venture Partner
NEW YORK, May 19, 2025 /PRNewswire/ -- J.P. Morgan Life Sciences Private Capital, the life sciences venture and growth equity arm within J.P. Morgan Asset Management, today announced the app...
05-19 22:00
Analyst Sees Bottom For Myriad Genetics Stock, Issues Upgrade
Piper Sandler upgrades Myriad Genetics to Overweight, citing stock stabilization and new leadership. The firm raises its price target to $12.50.
03-13 05:10
Ono Pharmaceutical completes tender offer for Deciphera
Ono Pharmaceutical has successfully completed its $2.4B tender offer for Deciphera Pharmaceuticals (NASDAQ:DCPH). As a result of the transaction, Deciphera is now a wholly owned subsidiary of Ono, wit...
2024-06-11 22:22
Deciphera Pharmaceuticals: Significant Post-Merger Corporate Changes
An update from Deciphera Pharmaceuticals (DCPH) is now available. Following the...
2024-06-11 21:59
Kuehn Law Encourages HIBB, CRGY, DCPH, and HCP Investors to Contact Law Firm
NEW YORK, June 3, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek...
2024-06-04 01:07
快讯 | Deciphera Pharmaceuticals预计在2024年第二季度提交新药申请并在2024年第三季度提交营销授权申请。
Deciphera Pharmaceuticals预计在2024年第二季度提交新药申请并在2024年第三季度提交营销授权申请。
2024-06-03 06:02
Deciphera Pharmaceuticals, Inc.'s (NASDAQ:DCPH) 74% Share Price Surge Not Quite Adding Up
Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) shareholders would be excited to ...
2024-05-24 20:51
Deciphera Pharmaceuticals(DCPH.US)：2024年Q1财报实现营收4499.9万美元，前值为3344.5万美元，预期值为4628万美元；每股收益为-0.52美元，前值为-0.60美元，预期值为-0.55美元。
Deciphera Pharmaceuticals(DCPH.US)：2024年Q1财报实现营收4499.9万美元，前值为3344.5万美元，预期值为4628万...
2024-05-10 21:21
ONO to acquire Deciphera Pharmaceuticals in $2.4B deal
ONO Pharmaceutical (OTCPK:OPHLY) to acquire all outstanding shares of Deciphera Pharmaceuticals (NASDAQ:DCPH) for $25.60 per share in cash through a tender offer, resulting in an equity value of appro...
2024-04-30 20:07
美股牛股 | FSD入华加速！特斯拉一夜飙升15%；飞利浦在美国达成11亿美元诉讼和解
飞利浦隔夜涨26.8%，就呼吸机致癌指控达成11亿美元和解；特斯拉隔夜涨15.3%，FSD入华加速>>
2024-04-30 18:57
